Brief: Galera Therapeutics Inc Announces Results Of Phase 3 Roman Trial Of Avasopasem For Radiotherapy-Induced Severe Oral Mucositis

Galera Therapeutics

19/10/2021 12:01

Oct 19 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA ANNOUNCES RESULTS OF PHASE 3 ROMAN TRIAL OF
AVASOPASEM
FOR RADIOTHERAPY-INDUCED SEVERE ORAL MUCOSITIS
    * GALERA THERAPEUTICS INC - AVASOPASEM WAS GENERALLY WELL
TOLERATED COMPARED TO PLACEBO
    * GALERA THERAPEUTICS INC - TRIAL DEMONSTRATED RELATIVE
REDUCTION
IN ALL KEY SOM ENDPOINTS, INCLUDING MORE THAN HALVING MEDIAN
DURATION
    * GALERA THERAPEUTICS INC - PRIMARY ENDPOINT OF REDUCTION IN
INCIDENCE OF SEVERE ORAL MUCOSITIS (SOM) NOT MET
    * GALERA THERAPEUTICS INC - TRIAL DID NOT MEET ITS PRIMARY
ENDPOINT OF REDUCTION IN INCIDENCE OF SOM

Source text for Eikon:  ID:nGNX1vWrF6 
Further company coverage:  GRTX.O 

 ((reuters.briefs@thomsonreuters.com;))